Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)

被引：1
|
作者：
Takemura, K. [1 ]
Navani, V. [1 ]
Ernst, M. S. [1 ]
Wells, J. C. [2 ]
Choueiri, T. K. [3 ]
Meza, L. [4 ]
Pal, S. K. [4 ]
Lee, J-L. [5 ]
Li, H. [5 ]
Agarwal, N. [6 ]
Alva, A. S. [7 ]
Hansen, A. R. [8 ]
Basappa, N. S. [9 ]
Szabados, B. E. [10 ]
Powles, T. B. [10 ]
Tran, B. [11 ]
Hocking, C. M. [12 ]
Beuselinck, B. [13 ]
Yuasa, T. [14 ]
Heng, D. Y. C. [1 ]
机构：
[1] Univ Calgary, Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] BC Canc Agcy, Med Oncol, Vancouver, BC, Canada
[3] Dana Farber Canc Inst, Med Oncol, Boston, MA USA
[4] City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA
[5] Univ Ulsan, Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea
[6] Univ Utah, Huntsman Canc Inst, Oncol, Salt Lake City, UT USA
[7] Univ Michigan, Hematol Oncol, Ann Arbor, MI USA
[8] Univ Hlth Network, Med Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] Univ Alberta, Med Oncol, Cross Canc Inst, Edmonton, AB, Canada
[10] Queen Mary Univ London, Genitourinary Oncol, Barts Canc Inst, London, England
[11] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[12] Lyell McEwin Hosp, Med Oncol, Adelaide, SA, Australia
[13] Katholieke Univ Leuven, Univ Hosp Leuven, General Med Oncol, Leuven, Belgium
[14] Japanese Fdn Canc Res, Urol, Canc Inst Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1455P
引用
收藏
页码：S1209 / S1210
页数：2
相关论文
共 50 条
  • [21] Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis
    Gupta, Mehul
    Wells, Connor
    Regan, Meredith M.
    Xie, Wanling
    Navani, Vishal
    Saliby, Renee Maria
    Basa, Naveen S.
    Donskov, Frede
    Yuasa, Takeshi
    Takemura, Kosuke
    Kollmannsberger, Christian K.
    Crumbaker, Megan
    Lalani, Aly-Khan A.
    Powles, Thomas
    Ebrahimi, Hedyeh
    Mckay, Rana R.
    Lee, Jae-Lyun
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (01): : 171 - 178
  • [22] The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)
    Ko, Jenny J.
    Xie, Wanling
    Heng, Daniel Yick Chin
    Kroeger, Nils
    Lee, Jae-Lyun
    Rini, Brian I.
    Knox, Jennifer J.
    Bjarnason, Georg A.
    Harshman, Lauren Christine
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Smoragiewicz, Martin
    Donskov, Frede
    Bamias, Aristotelis
    Wood, Lori
    Ernst, D. Scott
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [23] Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
    Yip, Steven M.
    Wells, Connor
    Moreira, Raphael
    Wong, Alex
    Srinivas, Sandy
    Beuselinck, Benoit
    Porta, Camillo
    Sim, Hao-Wen
    Ernst, D. Scott
    Rini, Brian I.
    Yuasa, Takeshi
    Basappa, Naveen S.
    Kanesvaran, Ravindran
    Wood, Lori A.
    Canil, Christina
    Kapoor, Anil
    Fu, Simon Y. F.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    CANCER, 2018, 124 (18) : 3677 - 3683
  • [24] Characterization of patients with metastatic renal cell carcinoma treated with or without cytoreductive nephrectomy in the era of combination immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
    Takemura, K.
    Ernst, M.
    Navani, V
    Wells, J. C.
    Bakouny, Z.
    Donskov, F.
    Basappa, N. S.
    Wood, L. A.
    Meza, L.
    Pal, S. K.
    Szabados, B.
    Powles, T.
    Beuselinck, B.
    Mckay, R. R.
    Lee, J-L
    Ernst, D. S.
    Kapoor, A.
    Yuasa, T.
    Choueiri, T. K.
    Heng, D. Y. C.
    EUROPEAN UROLOGY, 2023, 83 : S473 - S474
  • [25] The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)
    Navani, V.
    Ernst, M. S.
    Takemura, K.
    Pal, S. K.
    Powles, T. B.
    Donskov, F.
    Wells, J. C.
    Kollmannsberger, C. K.
    Beuselinck, B.
    Alva, A. S.
    Weickhardt, A. J.
    Lalani, A-K.
    Ernst, D. S.
    Agarwal, N.
    Choueiri, T. K.
    Heng, D. Y. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1215 - S1216
  • [26] Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)
    Stukalina, Igor
    Wellsa, J. Connor
    Donskovb, Frede
    Rinic, Brian I.
    Leed, Jae-Lyun
    Bjarnasone, Georg A.
    Beuselinckf, Benoit
    Smoragiewicz, Martin
    Alvah, Ajjai Shivaram
    Srinivasi, Sandy
    Woodi, Lori
    Saleemk, Sadia
    Pal, Sumanta Kumar
    Yuasam, Takeshi
    Broomn, Reuben James
    Kanesvaran, Ravindran
    Bamiasp, Aristotelis
    Knoxq, Jennifer J.
    Henga, Daniel Y. C.
    Choueirir, Toni K.
    BJU INTERNATIONAL, 2015, 116 : 21 - 21
  • [27] Cytoreductive nephrectomy (CN) in patients with synchronous metastases from renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Rini, Brian I.
    Beuselinck, Benoit
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Bjarnason, Georg A.
    Pal, Sumanta Kumar
    Kollmannsberger, Christian K.
    Yuasa, Takeshi
    Srinivas, Sandy
    Donskov, Frede
    Bamias, Aristotelis
    Wood, Lori
    Ernst, D. Scott
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Kim, Jenny J.
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [28] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Cabozantinib real-world effectiveness in the second-line setting of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Zarba, Martin
    O'Sullivan, Dylan
    El Hajj Chehade, Razane
    Mckay, Rana R.
    Pal, Sumanta Kumar
    Beuselinck, Benoit
    Donskov, Frede
    Lalani, Aly-Khan A.
    Crumbaker, Megan
    Li, Haoran
    Alva, Ajjai Shivaram
    Powles, Thomas
    Takemura, Kosuke
    Kollmannsberger, Christian K.
    Wong, Shirley S.
    Wood, Lori A.
    de Velasco, Guillermo
    Cheung, Winson Y.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [30] Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Wells, J. Connor
    Stukalin, Igor
    Norton, Craig
    Srinivas, Sandy
    Lee, Jae Lyun
    Donskov, Frede
    Bjarnason, Georg A.
    Yamamoto, Haru
    Beuselinck, Benoit
    Rini, Brian I.
    Knox, Jennifer J.
    Agarwal, Neeraj
    Ernst, D. Scott
    Pal, Sumanta K.
    Wood, Lori A.
    Bamias, Aristotelis
    Alva, Ajjai S.
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2017, 71 (02) : 204 - 209
12345